Startup · $32m raised
Melbourne-based biotech company advancing DEP HER2-Lutetium oncology program
Melbourne, VIC
Every investor coverage indicates participated in a round Starpharma raised.
| Investor | Rounds | Invested |
|---|---|---|
| Canaccord Genuity Australia | Unnamed stage | $500,000 |
Companies Starpharma acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Cheryl Maley | Chief Executive | Biotech Dispatch (26 Aug 2026), Biotech Dispatch (16 Jul 2026), kalkine.com.au, @AuManufacturing |
| Dr Jackie Fairley | CEPO (former) | @AuManufacturing (17 Nov 2023), @AuManufacturing (25 Oct 2023), @AuManufacturing (27 Jul 2023), @AuManufacturing (8 Mar 2023) |
| Justin Cahill | Chief Financial and Operations Officer and Company Secretary | kalkine.com.au, @AuManufacturing |
Stories naming Starpharma. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech Starpharma grew annual revenue on a Genentech licence payment, cut its loss, and completed a $30 million entitlement offer, giving it cash into 2028 to advance its cancer pipeline.
Australian biotech Starpharma has opened a 57-cent shareholder rights issue seeking about $32 million, with Canaccord Genuity underwriting the raise and an oversubscription facility letting holders apply for extra shares.
Also Biotech Dispatch·tipranks.com·kalkine.com.au·Biotech Dispatch
Manufacturing briefs: milk company results, a biotech shelving US studies, a rare earths R&D incentive, wind zone consultations, land tax anger, a big battery, a food tech centre launch, and a CEO appointment.
Roundup of Australian manufacturing news: Iluka's refinery cost estimate, a biotech placement with a founder sell-down, a CEO appointment, a retirement, an R&D refund, a distribution deal, a CRC merger and Victorian grants.
Briefs roundup: Main Sequence adds Alison Deans as venture partner; Starpharma hands the CEO role to Cheryl Maley; DroneShield lands a $2.2 million repeat order; Q-CTRL will deliver quantum training with QUIN.
Manufacturing briefs roundup: WA government commits $5m to space facility Fugro SpAARC; Starpharma and Micro-X receive R&D tax refunds; Bulla licenses Violet Crumble for ice cream; SCEE wins $50m in contracts.
Starpharma, two universities, Telix, Clarity and CSIRO launch an ARC-backed radiopharmaceutical research hub with a government grant and industry funding.
Briefs roundup: Starpharma names a new CFO, Weld Australia urges trades diversity, the Economic Accelerator bill passes, H2X Global enters AWS's clean energy accelerator, and A.H. Beard partners with the Sleep Health Foundation.
A manufacturing roundup covering a China milk powder supply deal, a methane emissions incentive, a nasal spray distribution agreement, a university space course, a government tax refund, and two companies' fresh capital raises.